EXCELERATE HEALTH VENTURES LLC

Thesis

Excelerate Health Ventures is a venture capital firm founded in 2013, specializing in Pharma Tech and tech-enabled pharma services. They focus on B2B SaaS companies that utilize capital-efficient models and Artificial Intelligence (AI) to accelerate time to market and enhance effectiveness within the pharmaceutical industry. The firm seeks companies with strong competitive advantages such as defensible moats, proprietary technology, data flywheels, or network effects. Their investment strategy includes a hands-on operational approach, offering strategic access to a network of customers, partners, advisors, and potential acquirers across the pharma, provider, and payer sectors. Excelerate Health Ventures primarily invests in Seed and Series A stage companies, often being the first institutional capital. Their geographic focus is the United States. The firm typically leads or co-leads investment rounds, with initial check sizes ranging from $500,000 to $2 million. They have a stated Assets Under Management (AUM) of over $70 million.

Related lists

• Seed-stage AI investors
• Seed-stage Enterprise investors
• Series A AI investors